Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy

Analysis of 1,115 Patients Tested for MET Amplification and Therapy Response in the MD Anderson Phase I Clinic

(2014) D. L. F. Jardim et al.   CLINICAL CANCER RESEARCH

Novel insights on the malignant transformation of endometriosis into ovarian carcinoma

(2014) Angiolo Gadducci et al.   GYNECOLOGICAL ENDOCRINOLOGY

Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma

(2014) Gian Franco Zannoni et al.   VIRCHOWS ARCHIV

Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignancies

(2014) Ramez N Eskander et al.   Expert Review of Clinical Pharmacology

Prevalence and Clinical Significance of Mammalian Target of Rapamycin Phosphorylation (p-mTOR) and Vascular Endothelial Growth Factor (VEGF) in Clear Cell Carcinoma of the Ovary

(2013) Nipon Khemapech et al.   Asian Pacific Journal of Cancer Prevention

Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinomaviaTRAIL-induced apoptotic pathway regulation

(2013) Kanako Shinjo et al.   INTERNATIONAL JOURNAL OF CANCER

Differences in LINE-1 Methylation Between Endometriotic Ovarian Cyst and Endometriosis-Associated Ovarian Cancer

(2013) Ajaree Senthong et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary

(2013) T. Hisamatsu et al.   MOLECULAR CANCER THERAPEUTICS

Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis

(2013) Yoriko Yamashita et al.   PLoS One

MET: A Critical Player in Tumorigenesis and Therapeutic Target

(2013) C. R. Graveel et al.   Cold Spring Harbor Perspectives in Biology

Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas

(2012) M T Rahman et al.   BRITISH JOURNAL OF CANCER

The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis

(2012) Hiroharu Kobayashi et al.   FERTILITY AND STERILITY

Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis

(2011) Fang Ren et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers

(2011) B. Guan et al.   CANCER RESEARCH

Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma

(2011) Shiro Suzuki et al.   CANCER SCIENCE

Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis

(2011) Yoo-Young Lee et al.   GYNECOLOGIC ONCOLOGY

Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis

(2011) Ching-wen Cheng et al.   JOURNAL OF PATHOLOGY

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas

(2011) Kimberly C Wiegand et al.   JOURNAL OF PATHOLOGY

Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient

(2011) Sohei Yamamoto et al.   MODERN PATHOLOGY

MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15-Dependent Manner in a Mouse Xenograft Model

(2011) C. Bartholomeusz et al.   MOLECULAR CANCER THERAPEUTICS

High risk for neoplastic transformation of endometriosis in a carrier of lynch syndrome

(2010) Christine Nyiraneza et al.   Familial Cancer

A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese

(2010) Satoko Uno et al.   NATURE GENETICS

ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas

(2010) Kimberly C. Wiegand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

(2010) Siân Jones et al.   SCIENCE

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

(2009) Kuan-Ting Kuo et al.   AMERICAN JOURNAL OF PATHOLOGY

Gynecologic cancers associated with Lynch syndrome/HNPCC

(2008) Kathleen M. Schmeler et al.   Clinical & Translational Oncology

Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress

(2008) K. Yamaguchi et al.   CLINICAL CANCER RESEARCH